Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database
C. Amigues, Audrey Fresse, C. Roux, S. Gauthier, Marie-Hélène Vieillard, Milou‐Daniel Drici, Véronique Breuil
Topics & Concepts
MedicineOsteonecrosis of the jawOsteoporosisDenosumabIncidence (geometry)BisphosphonatePharmacovigilanceInternal medicineZoledronic acidBisphosphonate-associated osteonecrosis of the jawAdverse effectOpticsPhysicsBone health and treatmentsParathyroid Disorders and TreatmentsBone and Joint Diseases